Apple AirPods Pro 3 vs Lexie B3

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid available at $250, earning a B grade with a SoundScore of 3.3/5 in our lab testing. This visible-in-ear device ranks #49 of 65 OTC hearing aids tested, placing it in the top 74% of its category. The standout performance area is music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during normal use. However, speech performance presents a more mixed picture: speech in quiet scores 2.3/5, falling 0.53 points below the category average, while speech in noise scores 1.8/5—above the category average but low in absolute terms. Own-voice comfort is a notable weakness at 1.9/5, scoring 0.61 points below the category average, which may affect how natural your own speech sounds while wearing the devices. The product showed meaningful improvement from tuning, with the normalized score rising from 3.2/5 to 3.8/5 after adjustment. The AirPods Pro 3 is best suited for users who prioritize music streaming quality and seamless Apple ecosystem integration over maximum speech clarity. Budget-conscious shoppers should note that several competitors in the same price range—including the Elehear Beyond and the previous-generation Apple AirPods Pro 2—achieved higher overall scores in our testing.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.